« Back to Research Deepdives

Macronutrients Associated with Cardiovascular Risk in the Population

This content is restricted to members.

To view our premium content, sign up for a membership:


Register New Account

Choose your membership level

Choose Your Payment Method

‹ Back to Research Deepdives


  1. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement fromthe European Atherosclerosis Society Consensus Panel. European Heart Journal. 2017;38(32):2459–72.
  2. Borén J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal. 2020;41(24):2313-2330.
  3. Keys A, Anderson JT, Grande F. Prediction of Serum-Cholesterol Responses of Man to Changes in Fats in the Diet. The Lancet. 1957;Nov 16(73(7003)):959=966.
  4. Hegsted MD, Ausman LM, Johnson JA, Dallal GE. Fat and Serum Lipids: The American Journal of Clinical Nutrition. 1993;57(6):875–83.
  5. Clarke R, Frost C, Collins R, Appleby PN, Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ. 1997;314:112–7.
  6. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Saturated fatty acids and risk of coronary heart disease: Modulation by replacement nutrients. Current Atherosclerosis Reports. 2010;12(6):384–90.
  7. Parks EJ. Changes in fat synthesis influenced by dietary macronutrient content. Proceedings of the Nutrition Society. 2002;61(2):281–6.
  8. Anderson JW. Dietary fiber prevents carbohydrate-induced hypertriglyceridemia. Current atherosclerosis reports. 2000;2(6):536–41.
  9. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: A systematic review and meta-analysis of randomized controlled trials. PLoS Medicine. 2010;7(3):e1000252.
  10. Hooper L, Martin N, Abdelhamid A, G DS. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database of Systematic Reviews. 2015;(6):1–150.
  11. Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia: REDUCE-IT. New England Journal of Medicine. 2019;380(1):11–22.
  12. Green CJ, Pramfalk C, Charlton CA, Gunn PJ, Cornfield T, Pavlides M, et al. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism. BMJ Open Diabetes Research & Care. 2020;8(1):e000871.
  13. Ahrens EH, Blankenhorn DH, Tsaltas TT. Effect on Human Serum Lipids of Substituting Plant for Animal Fat in Diet. Proc Soc Exp Biol Med. 1954;Aug-Sep(86(4)):872–8.
  14. Beveridge JMR, Connell WF, Mayer GA, Firstbrook JB, DeWolfe MS. The Effects of Certain Vegetable and Animal Fats on the Plasma Lipids of Humans. The Journal of Nutrition. 1955;56(2):311–20.
  15. Zong G, Li Y, Sampson L, Dougherty LW, Willett WC, Wanders AJ, et al. Monounsaturated fats from plant and animal sources in relation to risk of coronary heart disease among US men and women. American Journal of Clinical Nutrition. 2018;107(3):445–53.
  16. Yang Q, Zhang Z, Gregg EW, Flanders W, Merritt R, Hu FB. Added sugar intake and cardiovascular diseases mortality among us adults. JAMA Internal Medicine. 2014;39:376